Search

Ackermans & van Haaren NV

Closed

SectorFinance

239 1.44

Overview

Share price change

24h

Current

Min

235.4

Max

239

Key metrics

By Trading Economics

Income

273M

Sales

3B

P/E

Sector Avg

14.6

26.043

EPS

8.34

Dividend yield

1.63

Profit margin

9.008

Employees

24,384

EBITDA

627M

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+17.31% upside

Dividends

By Dow Jones

Dividend yield

Sector Avg

1.63%

4.04%

Market Stats

By TradingEconomics

Market Cap

1.4B

7.8B

Previous open

237.56

Previous close

239

News Sentiment

By Acuity

38%

62%

127 / 525 Finance

Ackermans & van Haaren NV Chart

Past performance is not a reliable indicator of future results.

Related News

6 Jan 2026, 21:14 UTC

Major Market Movers

Ventyx Biosciences Gains on Report of Possible $1 Billion Eli Lilly Deal

6 Jan 2026, 19:23 UTC

Acquisitions, Mergers, Takeovers

OneStream to Go Private Through $6.4 Billion Hg Acquisition

6 Jan 2026, 17:41 UTC

Major Market Movers

Blink Charging Shares Rise as EV Chargers Begin Accepting Cryptocurrency

6 Jan 2026, 15:46 UTC

Acquisitions, Mergers, Takeovers

Advent International Leads InPost Takeover Offer, Sky News Says

6 Jan 2026, 15:37 UTC

Major Market Movers

Terrestrial Energy Shares Rise After DOE Agreement For Nuclear Plant Development

6 Jan 2026, 23:46 UTC

Market Talk

Nikkei May Decline After Hitting Record High -- Market Talk

6 Jan 2026, 23:35 UTC

Market Talk

Gold Edges Higher Amid Ongoing Geopolitical Tensions -- Market Talk

6 Jan 2026, 23:19 UTC

Market Talk

Greatland 2Q Gold Output Strong, Sales Soft -- Market Talk

6 Jan 2026, 22:53 UTC

Market Talk

WiseTech, REA and CAR Look Best Insulated From AI Threat -- Market Talk

6 Jan 2026, 22:03 UTC

Acquisitions, Mergers, Takeovers

Staar Surgical: Merger Proposal Received 14.9M Votes For and 27.3M Against

6 Jan 2026, 22:03 UTC

Acquisitions, Mergers, Takeovers

Staar Surgical, Which Earlier Reported Stockholder Rejection of Sale to Alcon, Reports Vote Totals

6 Jan 2026, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

6 Jan 2026, 21:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

6 Jan 2026, 21:12 UTC

Market Talk

Market Talk Roundup: Latest on U.S. Politics

6 Jan 2026, 21:12 UTC

Market Talk

Commodity Demand Helps Canada Reduce Reliance on Trade With U.S. -- Market Talk

6 Jan 2026, 20:59 UTC

Major Market Movers
Acquisitions, Mergers, Takeovers

Ventyx Biosciences Gains on Report of Possible $1B Eli Lilly Deal

6 Jan 2026, 20:40 UTC

Acquisitions, Mergers, Takeovers

Acquisition of Ventyx Would Bring Lilly Into Emerging Category of Pills for Inflammation-Related Conditions -- WSJ

6 Jan 2026, 20:40 UTC

Acquisitions, Mergers, Takeovers

Eli Lilly Nears Deal for Biotech Ventyx -- WSJ

6 Jan 2026, 20:40 UTC

Acquisitions, Mergers, Takeovers

Deal Could Be Announced Imminently, Sources Say -- WSJ

6 Jan 2026, 20:40 UTC

Acquisitions, Mergers, Takeovers

Eli Lilly in Advanced Talks to Buy Ventyx Biosciences For Over $1B, Sources Say -- WSJ

6 Jan 2026, 20:01 UTC

Market Talk

Oil Futures Give Back Post-Venezuela Incursion Gains -- Market Talk

6 Jan 2026, 19:52 UTC

Market Talk

U.S. Natural Gas Falls Awaiting Colder Weather -- Market Talk

6 Jan 2026, 19:46 UTC

Acquisitions, Mergers, Takeovers

Under Armour Stock Rises After the 'Warren Buffet of Canada' Boosts Its Stake -- Barrons.com

6 Jan 2026, 19:08 UTC

Acquisitions, Mergers, Takeovers

OneStream to Go Private Through $6.4B Hg Acquisition

6 Jan 2026, 18:28 UTC

Acquisitions, Mergers, Takeovers

These Stocks Are Moving the Most Today: Sandisk, Nvidia, AMD, Palantir, OneStream, SoFi, Microchip, and More -- Barrons.com

6 Jan 2026, 17:20 UTC

Market Talk
Earnings

Financial Services Roundup: Market Talk

6 Jan 2026, 17:20 UTC

Market Talk
Acquisitions, Mergers, Takeovers

Health Care Roundup: Market Talk

6 Jan 2026, 15:57 UTC

Market Talk

Crude Futures Ease Back From Early Gains -- Market Talk

6 Jan 2026, 15:34 UTC

Market Talk
Earnings

Bank of Montreal Expects to Exit 2027 With ROE Hitting 15% Target -- Market Talk

6 Jan 2026, 15:27 UTC

Market Talk

German Inflation Won't Fall Much Further in 2026 -- Market Talk

Ackermans & van Haaren NV Forecast

Price Target

By TipRanks

17.31% upside

12 Months Forecast

Average 185 EUR  17.31%

High 185 EUR

Low 185 EUR

Based on 1 Wall Street analysts offering 12 month price targets forAckermans & van Haaren NV - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

1 ratings

1

Buy

0

Hold

0

Sell

Sentiment

By Acuity

127 / 525 Finance

News Sentiment

Bullish Evidence

Volatility

Below average

News Volume (RCV)

Average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Ackermans & van Haaren NV

Ackermans & Van Haaren NV engages in marine engineering and contracting, private banking, real estate and senior care, and energy and resources businesses worldwide. The Marine Engineering & Contracting segment engages in the marine construction activities, including dredging and civil works on water, as well as offshore activities in the areas of renewable energy, oil and gas, soil and sludge remediation, and aggregate and mineral extraction; real estate development, multitechnics, and construction and renovation activities; and development of port projects and related industrial zones, as well as offshore wind farms. The Private Banking segment offers discretionary asset management services for private clients; specialized advisory banking services for entrepreneurs and liberal professionals; and financing and financial leasing of cars, equipment, charging stations, and bicycles. The Real Estate & Senior Care segment develops mixed real estate projects, including redevelopment of iconic buildings and new constructions; and develops residential, and retail and office properties. The Energy & Resources segment produces crude palm oil and bananas; offers hybrid palm oil seeds; and manufactures cement. The AvH & Growth Capital provides engineering and solutions in production process automation; validation and compliance services; production and sale of compact biogas installations; manufactures and supplies specialty chemicals; provides broadcast and media solutions; online and printed news; logistics for rail and road transport, and intermodal transport, and warehousing services; develops new vaccines, and crop and food protection products; and deals and leases commercial vehicles, and distribution of aftermarket products. This segment also develops medical devices; medicines for the treatment of cancer and genetic diseases; and supplies medical equipment and consumables to hospitals through online. The company was founded in 1876 and is based in Antwerp, Belgium.
help-icon Live chat